[go: up one dir, main page]

EE200200168A - PRV-1-geen ja selle kasutamine - Google Patents

PRV-1-geen ja selle kasutamine

Info

Publication number
EE200200168A
EE200200168A EEP200200168A EEP200200168A EE200200168A EE 200200168 A EE200200168 A EE 200200168A EE P200200168 A EEP200200168 A EE P200200168A EE P200200168 A EEP200200168 A EE P200200168A EE 200200168 A EE200200168 A EE 200200168A
Authority
EE
Estonia
Prior art keywords
prv
gene
Prior art date
Application number
EEP200200168A
Other languages
English (en)
Inventor
Pahl Heike
Original Assignee
Universittsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universittsklinikum Freiburg filed Critical Universittsklinikum Freiburg
Publication of EE200200168A publication Critical patent/EE200200168A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EEP200200168A 1999-09-30 2000-09-29 PRV-1-geen ja selle kasutamine EE200200168A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947010A DE19947010A1 (de) 1999-09-30 1999-09-30 Das Gen PRV-1 und dessen Verwendung
PCT/EP2000/009594 WO2001023554A1 (de) 1999-09-30 2000-09-29 Das gen prv-1 und dessen verwendung

Publications (1)

Publication Number Publication Date
EE200200168A true EE200200168A (et) 2003-04-15

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200168A EE200200168A (et) 1999-09-30 2000-09-29 PRV-1-geen ja selle kasutamine

Country Status (21)

Country Link
EP (1) EP1220920A1 (et)
JP (1) JP2003510077A (et)
KR (1) KR20020047191A (et)
CN (1) CN1377408A (et)
AU (1) AU1132401A (et)
BG (1) BG106554A (et)
BR (1) BR0014444A (et)
CA (1) CA2387702A1 (et)
CZ (1) CZ20021094A3 (et)
DE (1) DE19947010A1 (et)
EA (1) EA200200286A1 (et)
EE (1) EE200200168A (et)
HR (1) HRP20020269A2 (et)
HU (1) HUP0203080A2 (et)
IL (1) IL148770A0 (et)
MX (1) MXPA02002800A (et)
NO (1) NO20021498L (et)
PL (1) PL354184A1 (et)
SK (1) SK4262002A3 (et)
WO (1) WO2001023554A1 (et)
ZA (1) ZA200202379B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
KR102031317B1 (ko) 2012-05-21 2019-10-14 제넨테크, 인크. 혈액-뇌 장벽 수송의 안전성을 개선하는 방법
WO2018229179A1 (en) * 2017-06-14 2018-12-20 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063088A2 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Membrane-bound proteins and nucleic acids encoding the same
WO1998050552A1 (en) * 1997-05-06 1998-11-12 Zymogenetics, Inc. Novel tumor antigens
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
KR100468977B1 (ko) * 1998-12-16 2005-02-02 제넨테크, 인크. 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산

Also Published As

Publication number Publication date
PL354184A1 (en) 2003-12-29
CZ20021094A3 (cs) 2002-06-12
EP1220920A1 (de) 2002-07-10
IL148770A0 (en) 2002-09-12
BR0014444A (pt) 2002-06-11
HRP20020269A2 (en) 2003-06-30
ZA200202379B (en) 2003-10-29
MXPA02002800A (es) 2002-07-22
NO20021498D0 (no) 2002-03-26
WO2001023554A1 (de) 2001-04-05
AU1132401A (en) 2001-04-30
SK4262002A3 (en) 2002-09-10
BG106554A (bg) 2003-01-31
CA2387702A1 (en) 2001-04-05
CN1377408A (zh) 2002-10-30
NO20021498L (no) 2002-05-23
HUP0203080A2 (hu) 2002-12-28
JP2003510077A (ja) 2003-03-18
EA200200286A1 (ru) 2002-12-26
KR20020047191A (ko) 2002-06-21
DE19947010A1 (de) 2001-04-05

Similar Documents

Publication Publication Date Title
EE05169B1 (et) Asendatud oksasolidinoonid ja nende kasutamine
EE04452B1 (et) Farmatseutiliselt aktiivne morfolinool ja selle kasutamine
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
EE05210B1 (et) Suhkurt?vevastane preparaat ja selle kasutamine meditsiinis
EE200200175A (et) Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
ID26599A (id) Turunan triazola dan imidazola
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DE60014955D1 (de) Schraubzange
EE200200282A (et) Keemilised meetodid ja vaheühendid
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
EP1210084A4 (en) PYRIDOMORPHINANS, THIENOMORPHINANS AND THEIR USE
NO20021604D0 (no) Leptin assay
NO20021305D0 (no) DNA-konstruksjon og dens anvendelse
EE200200096A (et) IREN-valk, selle valmistamine ja kasutamine
EE200200168A (et) PRV-1-geen ja selle kasutamine
ID25567A (id) Ulir-jepit dengan bahu-puntir
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
EP1417218A4 (en) TETRAHYMENA METALLOTHION IN GENE PROMOTER AND ITS USE
EP1241256A4 (en) NEW GENE AND ITS USE
FI980680L (fi) Rakenne ja sen käyttö
NO20015906D0 (no) Spliceosomprotein og dets anvendelse
SE9903962D0 (sv) Ny användning
SE9901136D0 (sv) Ny användning